...
首页> 外文期刊>Medicine. >Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy.
【24h】

Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy.

机译:肝移植对家族性淀粉样蛋白多神经病心脏自主神经的影响。

获取原文
获取原文并翻译 | 示例

摘要

Familial amyloid polyneuropathy (FAP) is a rare and severe hereditary form of amyloidosis, due to the deposition of a genetic variant transthyretin essentially produced by the liver, and characterized by both sensorimotor and autonomic neuropathy. Liver transplantation (LT) is the most effective treatment to stop the progression of the disease. Cardiac amyloid infiltration is usually associated with cardiac denervation, restrictive cardiomyopathy, conduction disturbances, and sometimes sudden death. Whether the cardiac involvement related to amyloid deposition may be altered after LT remains unclear. We conducted the present study to define the outcome of cardiac involvement after LT in 31 patients with FAP (age, 39 +/- 12 yr). Patients were evaluated before and after LT (24 +/- 15 mo). Cardiac sympathetic denervation was assessed by both iodine-123 metaiodobenzylguanidine (MIBG) scintigraphy and heart rate variability (HRV) analysis. The scintigraphic importance of sympathetic denervation was evaluated globally on planar imaging using heart-to-mediastinum activity ratio (H/M) measured 4 hours after injection, and regionally using single-photon emission tomography (SPET) imaging. Amyloid myocardial infiltration was assessed by echocardiography. Diffuse sympathetic denervation was found when using cardiac MIBG planar imaging in patients evaluated before LT and compared with 12 control subjects (H/M: 1.45 +/- 0.29 vs. 1.98 +/- 0.35, p < 0.001). On SPET images, defects were diffuse in 12 patients and focal in 19 patients, with predominance at the inferior and apical segments. No change in sympathetic innervation was found in patients after LT as assessed either with planar imaging (H/M after LT: 1.46 +/- 0.28, p = not significant vs. H/M before LT) or with SPET imaging. HRV nonspectral indexes showed that the standard deviation of all cycles was significantly lower in patients compared with control subjects, and remained unchanged after LT. Conduction disturbances and ventricular arrhythmias were associated with low cardiac MIBG uptake, and progressed after LT. The left ventricular wall was slightly thickened in patients, and a further increase was observed after LT (posterior wall from 9.2 +/- 1.8 to 10.1 +/- 2.3 mm, p = 0.02; septal wall from 10.6 +/- 2.7 to 12.1 +/- 4, p = 0.046). Neurologic status stabilized in 26 patients, but worsened in the 5 patients who had the most severe cardiac sympathetic denervation before LT as measured by MIBG imaging. The magnitude of the cardiac sympathetic denervation remained stable 2 years after LT in patients with FAP, whereas the cardiac amyloid infiltration progressed. The importance of cardiac sympathetic denervation found in FAP patients before LT was associated with a neurologic worsening after LT.
机译:家族性淀粉样变性神经病(FAP)是淀粉样变性病的罕见且严重的遗传形式,这是由于沉积了基本上由肝脏产生的遗传变异型运甲状腺素蛋白,其特征是感觉运动和自主神经病变。肝移植(LT)是阻止疾病进展的最有效方法。心脏淀粉样蛋白浸润通常与心脏神经支配,限制性心肌病,传导障碍以及有时猝死有关。尚不清楚LT后是否会改变与淀粉样蛋白沉积有关的心脏受累情况。我们进行了本研究以定义31例FAP患者(39岁+/- 12岁)的LT后心脏受累的结果。在LT(24 +/- 15 mo)之前和之后对患者进行评估。通过碘123碘碘苄基胍(MIBG)闪烁显像和心率变异性(HRV)分析评估了心脏交感神经的去神经。在注射后4小时测得的心脏与纵隔活动度(H / M),在平面成像上,以及在单区域使用单光子发射断层扫描(SPET)成像,在平面成像上全面评估了交感神经的闪烁显像重要性。通过超声心动图评估淀粉样蛋白心肌浸润。当在LT前评估的患者中使用心脏MIBG平面成像并与12个对照受试者进行比较时,发现了弥漫性交感神经支配(H / M:1.45 +/- 0.29对1.98 +/- 0.35,p <0.001)。在SPET图像上,缺陷弥漫在12例患者中,病灶在19例中,以下端和心尖段为主。经平面成像(LT后H / M:1.46 +/- 0.28,p =与LT前H / M相比无显着性)或SPET成像评估,LT后患者的交感神经没有变化。 HRV非光谱指数显示,与对照组相比,患者所有周期的标准差均显着降低,LT后保持不变。传导障碍和室性心律失常与心脏MIBG摄取低有关,并在LT后进展。患者的左心室壁稍增厚,LT后观察到进一步增加(后壁从9.2 +/- 1.8增至10.1 +/- 2.3 mm,p = 0.02;间隔壁从10.6 +/- 2.7增至12.1 + /-4,p = 0.046)。通过MIBG成像测量,在26例患者中神经系统状况稳定,但在LT之前最严重的心脏交感神经失调的5例患者中神经状况恶化。 FAP患者LT后2年,心脏交感神经去神经的幅度保持稳定,而心脏淀粉样蛋白浸润进展。 LT之前在FAP患者中发现心脏交感神经的重要性与LT之后神经系统恶化有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号